On September 2, 2015, Entia Biosciences Inc. and Devin Andres mutually agreed to the termination of Mr. Andres' position as Chief Operating Officer of the company.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | -.--% | -.--% | -.--% |
2017 | Entia Biosciences, Inc. Announces Management Changes | CI |
2017 | Entia Biosciences, Inc Auditor Raises 'Going Concern' Doubt | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 3.41K | |
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+50.01% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
-1.51% | 11.99B |
- Stock Market
- Equities
- ERGO Stock
- News Entia Biosciences, Inc.
- Entia Biosciences, Inc. Announces Termination of Devin Andres as Chief Operating Officer